Skip to content

Evaluation of upper limb motor performances using tablet-based tests

Evaluation of upper limb motor performances using tablet-based tests

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009022
Enrollment
160
Registered
2015-08-07
Start date
2015-08-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with stroke (I64), multiple sclerosis (G35), Parkinson disease (G20) and ataxia (R27) who suffers from arm disabilities I64 G35 G20 R27 U50

Interventions

Group 1: We will collect data with healthy subjects of different age (6 age groups: 21-30, 31-40, 41-50, 51-60, 61-70, 71-80) and gender (2 categories). Four tests on a tablet will be repeated 5 times

Sponsors

ReHaptix GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 80 Years

Inclusion criteria

Inclusion criteria: Healthy subjects will be eligible for the study if they have full hand function and can perform any activity of daily living involving the hands. Impaired subjects will be eligible for the study if they are mildly to moderately impaired. They should be capable to perform minimal arm and hand movements but suffer from impaired motor function hindering typical activities of daily living.

Exclusion criteria

Exclusion criteria: Healthy subjects will not be eligible for the study if they suffer from impaired motor function hindering typical activities of daily living. Impaired subjects will not be eligible for the study if they fully recovered and are not suffering from impaired motor function hindering typical activities of daily living.

Design outcomes

Primary

MeasureTime frame
The study aims at: 1) measuring performances of healthy subjects as reference norms for comparison with patients data 2) validate the results by comparing them to existing validated clinical measures 3) evaluating the test-retest reliability of the results

Secondary

MeasureTime frame
The study also aims at developing additional outcome measures for the tablet based tests by analysing performances from healthy subjects and patients.

Countries

Switzerland

Contacts

Public ContactMarie-Christine Fluet

ReHaptix GmbH

fluet@rehaptix.com+41 76 454 2588

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026